The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
The effect that β-lactam antibiotics have on progression free and overall survival in multiple myeloma patients undergoing autologous stem cell transplantation.
 
Marshall McKenna
No Relationships to Disclose
 
Rena Feinman
No Relationships to Disclose
 
Jaeil Ahn
No Relationships to Disclose
 
Shuqi Wang
No Relationships to Disclose
 
David H. Vesole
Stock and Other Ownership Interests - Abbvie; Amgen; Biogen; Gilead Sciences; Johnson & Johnson; Lilly; Novartis
Honoraria - Amgen; Celgene; Takeda
Speakers' Bureau - Amgen; Celgene; Janssen Oncology; Takeda
 
Stuart L. Goldberg
Employment - COTA
Stock and Other Ownership Interests - COTA
Consulting or Advisory Role - Bristol-Myers Squibb
Research Funding - Bristol-Myers Squibb (Inst); Celator (Inst); Novartis (Inst)
 
Giselle Alexandra Suero-Abreu
No Relationships to Disclose
 
Miguel Gonzalez Velez
No Relationships to Disclose
 
Jun Chih Wang
No Relationships to Disclose
 
Abdul Rehman
No Relationships to Disclose
 
Phyllis McKiernan
No Relationships to Disclose
 
Michele Donato
Research Funding - Merck (Inst)
 
Elli Gourna Paleoudis
No Relationships to Disclose
 
David Samuel DiCapua Siegel
Stock and Other Ownership Interests - Celularity
Consulting or Advisory Role - Amgen; Bristol-Myers Squibb; Celgene; Janssen; Karyopharm Therapeutics; Merck; Takeda
Speakers' Bureau - Amgen; Bristol-Myers Squibb; Celgene; Janssen; Takeda
Research Funding - Celgene (Inst)
 
Noa Biran
Honoraria - Amgen; Bristol-Myers Squibb; Celgene; Janssen Oncology; Takeda
Consulting or Advisory Role - Amgen; Celgene; Takeda
Speakers' Bureau - Amgen; Bristol-Myers Squibb; Celgene; Janssen; Takeda
Research Funding - Bristol-Myers Squibb (Inst); Karyopharm Therapeutics (Inst); Merck (Inst)